期刊
JOURNAL OF ETHNOPHARMACOLOGY
卷 141, 期 2, 页码 728-735出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jep.2011.08.011
关键词
Huang-Lian-Jie-Du-Tang; LC/MS; Metabolites; Traditional Chinese medicine; Plasma pharmacochemistry
资金
- Program for Changjiang Scholars and Innovative Team in University (PCSIRT)
- NCET Foundation, NSFC [30725045]
- National 863 Program [2006-AA02Z338]
- China Postdoctoral Science Foundation [20070410711]
- 973 program of China [2007CB-507400]
- Shanghai Leading Academic Discipline Project [B906]
- Scientific Foundation of Shanghai China [07DZ19728, 06DZ19717, 06DZ19005]
Ethnopharmacological relevance: Huang-Lian-Jie-Du-Tang (HLJDT), a classic prescription of traditional Chinese medicine (TCM), has been used in clinical over 1700 years for the treatment of gastrointestinal disorders, cardiovascular diseases and Alzheimer disease. But the active components of HLJDT were ambiguous, which seriously restricted its clinical application. Materials and methods: The methodology of plasma pharmacochemistry was applied to screen the bioactive components in HLJDT. A reliable LC/MS system was established for detecting the prototype compounds and metabolites in dosed plasma after oral administration of HLJDT. By comparative analysis of the chemical profiles of HLJDT extracts, blank plasma and dosed plasma, potential bioactive compounds in HLJDT may be discovered. Results: By comparing the retention time, MS and MS/MS spectra with those of reference standard and literature data, 30 components including 22 prototype compounds and 8 metabolites from HLJDT were discovered as potential bioactive components in rat plasma. Conclusions: A reliable and effective method was established to screen the potential bioactive components in the formula of HLJDT, which provided useful information for the further study of action mechanism of HLJDT. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据